SERD
A selective estrogen receptor degrader or downregulator (SERD) is a type of drug that selectively binds to the estrogen receptor (ER) and induces its degradation, and thus causes its downregulation. SERDs are used in the treatment of estrogen receptor-positive breast cancer, particularly in cases where tumors have developed resistance to other forms of endocrine therapy, such as selective estrogen receptor modulators (SERMs) or aromatase inhibitors.
Recent news mentioning SERD
- — SERD Market Set for Growth During the Forecast Period (2026-2036) as AstraZeneca's ETCAMAH Approval Accelerates Adoption of Oral SERDs | DelveInsight
- — EyeROV: Indisches Deep-Tech-Startup präsentiert seine Unterwasserdrohnen vor führenden Politikern aus aller Welt
- — Silicon Line®, une marque d'EverProX®, lance le nouveau chipset SerDes à très faible consommation MSDL™ (MIPI Serial Data Link), qui étend la connectivité MIPI D-PHY à 20 Gbit/s sur des distances de plusieurs dizaines de mètres
- — Silicon Line®, una marca EverProX®, lanza el nuevo chipset SerDes de ultrabajo consumo MSDL™
- — Grund- und Oberflächenwasser: Forscher: Wasserdefizit in Deutschland verschlimmert sich
- — Silicon Line®, eine Marke von EverProX®, bringt das neue Ultra-Low-Power-SerDes-Chipset MSDL™ (MIPI Serial Data Link) auf den Markt und ermöglicht damit MIPI-D-PHY-Verbindungen mit 20 Gbit/s über Distanzen von mehreren Dutzend Metern
- — Silicon Line®, an EverProX® brand, Launches new Ultra-Low-Power SerDes Chipset MSDL™ (MIPI Serial Data Link), Extending 20 Gbps MIPI D-PHY Connectivity to Tens of Meters
- — Silicon Line®, an EverProX® brand, Launches new Ultra-Low-Power SerDes Chipset MSDL™ (MIPI Serial Data Link), Extending 20 Gbps MIPI D-PHY Connectivity to Tens of Meters